He et al. [61] demonstrated that MXRA5 was aberrantly expressed in nonsmall cell lung cancer (NSCLC) tissue at the RNA and protein level and correlated with poor clinical outcomes. The gene discussed is MXRA5; the disease is non-small cell lung carcinoma.